[PP-25] Travellers medicine

[(W)P-280] Update on the Development of Takeda’s Live Attenuated Tetravalent Dengue Vaccine Candidate (TAK-003)

^○CHOO GOH¹, Xavier Sez-Llorens², Delia Yu³, Luis Rivera⁴, Astrid Borkowski⁵, Derek Wallace⁶ (1.TAKEDA VACCINES PTE LTD, 2.Hospital del Nio Dr. Jos Renn Esquivel, Panama City, Panama, 3.De La Salle Health Sciences Institute, Dasmarias, Philippines, 4.Hospital Maternidad Nuestra Senora de La Altagracia, Santo Domingo, Dominican Republic, 5.Takeda Pharmaceuticals International AG, Zurich, Switzerland, 6.Takeda Pharmaceuticals International, Cambridge, MA 02139, USA)